ArticleScientific reports2019

Neprilysin Inhibitor-Angiotensin II Receptor Blocker Combination Therapy (Sacubitril/valsartan) Suppresses Atherosclerotic Plaque Formation and Inhibits Inflammation in Apolipoprotein E- Deficient Mice.

Hui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.